230 related articles for article (PubMed ID: 8238731)
1. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
Goldblum JR; Bartos RE; Carr KA; Frank TS
Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
[TBL] [Abstract][Full Text] [Related]
2. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
4. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
6. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between mutation of tumor suppressor gene p53 and development of hepatocellular carcinoma].
Zhu MH
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):245-7. PubMed ID: 7909744
[TBL] [Abstract][Full Text] [Related]
8. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
9. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
[TBL] [Abstract][Full Text] [Related]
12. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
Bressac B; Kew M; Wands J; Ozturk M
Nature; 1991 Apr; 350(6317):429-31. PubMed ID: 1672732
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
[TBL] [Abstract][Full Text] [Related]
14. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
15. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
Liu H; Wang Y; Zhou Q; Gui SY; Li X
World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
[TBL] [Abstract][Full Text] [Related]
16. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
Challen C; Lunec J; Warren W; Collier J; Bassendine MF
Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
[TBL] [Abstract][Full Text] [Related]
18. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
Coursaget P; Depril N; Chabaud M; Nandi R; Mayelo V; LeCann P; Yvonnet B
Br J Cancer; 1993 Jun; 67(6):1395-7. PubMed ID: 8390289
[TBL] [Abstract][Full Text] [Related]
20. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
